News - Appointment of VP for communications/relations 2019-03-18 08:00 ET - News Release
VICTORIA, British Columbia, March 18, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald" or the “Company”) (TSXV:EMH; OTCQX:EMHTF) announced today that Allan Rewak has been appointed Vice President, Communications and Stakeholder Relations, effective April 15, 2019.
.
Prior to joining Emerald, Mr. Rewak was the Executive Director at the Cannabis Council of Canada (C3), Canada’s national industry association for cannabis, cultivators and processors. In the role, he unified multiple industry associations into one collective and navigated the sector through the successful legalisation of adult-use cannabis. For his work, the Financial Post named him “One of the 20 Power Players Setting Down Roots in the Cannabis Industry”.
Mr. Rewak also served as Director of Communications and Stakeholder Relations at Newstrike Resources, a partner at Pathway Group, and a consultant at Leonard Domino & Associates.
.
“We are pleased to welcome Allan to the Emerald team,” said Dr. Avtar Dhillon, Executive Chairman and President of Emerald. “His deep industry relationships and proven experience in the sector, combined with his strong background in communications and stakeholder relations with all major relevant sectors of the industry, are expected to augment our existing capabilities.”
.
Mr. Rewak has been granted an option to acquire up to 150,000 common shares vesting over a three-year period.
https://www.stockwatch.com/Quote/Detail.aspx?symbol=EMH®ion=C